$CVM 4 SEC Filings

Filed On	Filing
01 Oct 2026	Form 4: Prichep Patricia B, Chief Financial Officer Received 2,082 shares as a grant or award ($4.29K)
01 Oct 2026	Form 4: Talor Eyal, Chief Scientific Officer Received 1,165 shares as a grant or award ($2.4K)
01 Oct 2026	Form 4: Kersten Geert R, Director Received 2,621 shares as a grant or award ($5.4K)
26 Aug 2026	Form 4: Kersten Geert R, Director Bought 100,000 shares ($138K)
17 Aug 2026	Form 4: Watson Robert Eugene, Director Granted 110,000 Options ($1.1K)
17 Aug 2026	Form 4: Baillavoine Bruno Jean-marie, Director Granted 110,000 Options ($1.1K)
17 Aug 2026	Form 4: Cipriano John, Senior Vice President Granted 80,000 Options ($800)
17 Aug 2026	Form 4: Prichep Patricia B, Chief Financial Officer Granted 225,000 Options ($2.25K)
17 Aug 2026	Form 4: Kersten Geert R, Director Granted 300,000 Options ($3K)
17 Aug 2026	Form 4: Talor Eyal, Chief Scientific Officer Granted 250,000 Options ($2.5K)
01 Jul 2026	Form 4: Prichep Patricia B, Chief Financial Officer Received 4,125 shares as a grant or award ($4.29K)
01 Jul 2026	Form 4: Talor Eyal, Chief Scientific Officer Received 2,307 shares as a grant or award ($2.4K)
01 Jul 2026	Form 4: Kersten Geert R, Director Received 5,192 shares as a grant or award ($5.4K)
18 May 2026	Form 4: Kersten Geert R, Director Bought 300,000 shares ($360K)
14 May 2026	Form 4: Kersten Geert R, Director Bought 100,000 shares ($119K)
01 Apr 2026	Form 4: Talor Eyal, Chief Scientific Officer Received 747 shares as a grant or award ($2.4K)
01 Apr 2026	Form 4: Prichep Patricia B, Chief Financial Officer Received 1,336 shares as a grant or award ($4.29K)
01 Apr 2026	Form 4: Kersten Geert R, Director Received 1,682 shares as a grant or award ($5.4K)
26 Jan 2026	Form 4: Kersten Geert R, Director Bought 38,023 shares ($200K)
05 Jan 2026	Form 4: Talor Eyal, Chief Scientific Officer Received 456 shares as a grant or award ($2.4K)

Comments